A new name for polycystic ovary syndrome (PCOS), the most common cause of infertility, has been proposed by medical experts to better reflect the underlying metabolic and hormonal issues. The condition, which affects up to 10% of women of reproductive age, has long been criticized for its misleading name, as not all women with PCOS have ovarian cysts. The proposed name aims to reduce stigma and improve diagnosis and treatment.
Why a Name Change Matters
Experts argue that the current name focuses on a symptom that is not universal, leading to confusion and delayed diagnosis. PCOS is a complex endocrine disorder involving insulin resistance, high androgen levels, and irregular periods. A more accurate name could help patients and doctors recognize the condition earlier.
Impact on Patients
Many women with PCOS face years of misdiagnosis or dismissal of symptoms. The name change is part of a broader effort to improve awareness and care. Advocacy groups have welcomed the proposal, noting that language shapes perception and treatment.
Next Steps
The proposal will be reviewed by international medical societies. If approved, it could take effect within a year, with updated guidelines for healthcare providers.
